Freenome, Inc. (FRNM)
NASDAQ: FRNM · Real-Time Price · USD
13.63
+0.18 (1.34%)
At close: Aug 19, 2026, 4:00 PM EDT
13.67
+0.04 (0.29%)
After-hours: Aug 19, 2026, 7:34 PM EDT
Freenome Employees
Freenome had 363 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
363
Change
n/a
Growth
n/a
Revenue / Employee
$94,317
Profits / Employee
-$619,912
Market Cap
1.54B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 363 | 0 | - | 363 | 0 |
| Dec 31, 2025 | 363 | 5 | 1.40% | 363 | 0 |
| Dec 31, 2024 | 358 | - | - | 353 | 5 |
Related Stocks
| Company Name | Employees |
|---|---|
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| GeneDx Holdings | 1,300 |
| Castle Biosciences | 1,002 |
| GRAIL | 910 |
| CareDx | 765 |
| Veracyte | 755 |
FRNM News
- 1 day ago - Freenome files to sell 75.19M shares of common stock for holders - TheFly
- 1 day ago - Freenome initiated with a Buy at TD Cowen - TheFly
- 2 days ago - Freenome initiated with a Buy at BTIG - TheFly
- 2 days ago - Freenome granted Breakthrough Device Designation for SimpleScreen Lung - TheFly
- 2 days ago - Freenome initiated with a Buy at Jefferies - TheFly
- 3 days ago - Freenome initiated with an Outperform at Leerink - TheFly
- 7 days ago - FDA Grants Breakthrough Device Designation to Freenome's Blood-Based SimpleScreen™ Lung Cancer Screening Test - GlobeNewsWire
- 23 days ago - FDA approves Freenome's blood test for colorectal cancer screening - Reuters